CUMBERLAND PHARMACEUTICALS INC.

Insiders Cumberland Pharmaceuticals Inc.

Equities

CPIX

US2307701092

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-07 pm EDT			5-day change	1st Jan Change
1.58 ^USD	+3.27%		-1.25%	-11.82%

May. 07	Earnings Flash (CPIX) CUMBERLAND PHARMACEUTICALS Reports Q1 Revenue $8.5M	MT
Mar. 13	Tranche Update on Cumberland Pharmaceuticals Inc.'s Equity Buyback Plan announced on May 13, 2010.	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Cumberland Pharmaceuticals Inc. Announces Demise of Joey A. Jacobs, Member of Board of Directors	23-01-17	CI
Cumberland Pharmaceuticals Appoints Martin Brown Jr. to Its Board of Directors	22-07-19	CI
Cumberland Pharmaceuticals Inc. Announces Executive Changes	22-06-03	CI
Cumberland Pharmaceuticals Inc. Announces Executive Changes	22-03-22	CI
Cumberland Pharmaceuticals Inc. Promotes John Hamm to Director Finance Accounting	21-05-20	CI
Cumberland Pharmaceuticals Inc. Names John Hamm as Chief Financial Officer	21-05-19	CI
Cumberland Pharmaceuticals Inc. Appoints John Hamm as the Senior Director Finance & Accounting, Effective May 17, 2021	21-05-14	CI
Cumberland Pharmaceuticals Inc. Appoints Caroline R. Young as First ESG Board Director	20-05-20	CI
Martin E. Cearnal Resigns as Class III Director of Cumberland Pharmaceuticals Inc	19-09-20	CI
Cumberland Pharmaceuticals Inc. Appoints Joseph C. Galante as Member of Board of Directors	18-09-21	CI
Cumberland Pharmaceuticals Appoints Adam Haeberle as Senior Director, Clinical and Regulatory Affairs	18-08-13	CI
Cumberland Pharmaceuticals Inc. Appoints Chris Bitterman as Hospital Sales Director	18-05-07	CI
Cumberland Pharmaceuticals Appoints Kenneth J. Krogulski to Board of Directors, Effective January 18, 2017	17-01-16	CI
Cumberland Pharmaceuticals Announces the Addition of Caroline Young to its Board of Directors	16-06-10	CI
Cumberland Pharmaceuticals Inc. Promotes Amy D. Rock to Vice President, Regulatory & Scientific Affairs	16-02-05	CI
Cumberland Pharmaceuticals Inc. Appoints Michael Bonner as Senior Director Finance and Accounting and Chief Financial Officer Effective February 1, 2016	16-02-01	CI
Cumberland Pharmaceuticals, Inc. Announces Executive Changes	15-10-02	CI
Cumberland Pharmaceuticals, Inc. : Cumberland Pharmaceuticals Named in Mordern Healthcare's Inaugural Healthcare's Hottest Recognition Program	12-08-23	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW